Comparative Pharmacology
Head-to-head clinical analysis: HC 1 versus NUTRACORT.
Peer-Reviewed Evidence
Head-to-head clinical analysis: HC 1 versus NUTRACORT.
HC #1 vs NUTRACORT
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Unknown
Corticosteroid receptor agonist; induces anti-inflammatory proteins and suppresses inflammatory mediators.
Hydrocortisone: 100-200 mg IV as initial dose, then 50-100 mg IV every 6 hours, or 0.18 mg/kg/h IV continuous infusion.
One capsule (200 mg) orally twice daily with meals.
None Documented
None Documented
2–4 hours (terminal); prolonged in renal impairment.
Terminal half-life: 2-4 hours (mean 3 hours). Clinically, dosing every 6-8 hours maintains therapeutic levels.
Renal: 90% as unchanged drug; fecal: 10%.
Renal (primarily as glucuronide and sulfate conjugates, <10% unchanged) and fecal (biliary excretion of metabolites). Approximately 70-80% renal, 20-30% fecal.
Category C
Category C
Topical Corticosteroid
Topical Corticosteroid